author-photo

Salvatore Buffardi

Boston Children's Hospital

48

Papers

399

Citations

Citation Trend

Filter By

Papers (34) Sort By

Journal Conference Others

Proteomic Exploration of Plasma Exosomes and Other Small Extracellular Vesicles in Pediatric Hodgkin Lymphoma: A Potential Source of Biomarkers for Relapse Occurrence

2021
Show All
- Source
- Cite
- Save
Citations (0)
A Score for Predicting Freedom from Progression of Children and Adolescents with Hodgkin Lymphoma

2021
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic Role of Minimal Disseminated Disease and NOTCH1/FBXW7 Mutational Status in Children with Lymphoblastic Lymphoma: The AIEOP Experience.

2021
Show All
- Source
- Cite
- Save
Citations (0)
HL-032: Nivolumab and Brentuximab Vedotin (BV)–Based, Response-Adapted Treatment in Children, Adolescents, and Young Adults (CAYA) With Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL): Primary Analysis of the Standard-Risk Cohort of the Phase 2 CheckMate 744 Study

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Minimal residual disease analysis in childhood mature B‐cell leukaemia/lymphoma treated with AIEOP LNH‐97 protocol with/without anti‐CD20 administration

2020 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (6)
Comparative proteomic profiling in recurrent pediatric/adolescent Hodgkin Lymphoma

2020
Show All
- Source
- Cite
- Save
Citations (0)
Comparison of Hodgkin's Lymphoma in Children and Adolescents. A Twenty Year Experience with MH'96 and LH2004 AIEOP (Italian Association of Pediatric Hematology and Oncology) Protocols.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (3)
Nivolumab and brentuximab vedotin (BV)-based, response‐adapted treatment in children, adolescents, and young adults (CAYA) with standard-risk relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Primary analysis.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
RNA-seq analysis of plasmatic exosomal miRNAs in pediatric Hodgkin Lymphoma

2020
Show All
- Source
- Cite
- Save
Citations (0)
Are event-free survival and freedom-from progression compromised by reduced radiation doses fields? Comparison between the results of the AIEOP (Italian Association of Pediatric Hematology and Oncology) LH-2004 & MH96 Protocols

2020
Show All
- Source
- Cite
- Save
Citations (0)